{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"14.3","upperLimit":"25.5","value":"17.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"26"}],"units":"Participants"}],"description":"Apparent terminal half-life (h), calculated as (ln 2)/λz. Calculated for the C1D1 dose only.","dispersionType":"Full Range","groups":[{"description":"PK Sampling C1D1","id":"OG000","title":"C1D1"}],"paramType":"MEDIAN","populationDescription":"PK population includes all subjects, at the selected sites in Japan and all sites in South Korea, who have pretreatment baseline and at least 1 blood sample on study providing PK data for HBI-8000.","reportingStatus":"POSTED","timeFrame":"0 (predose) up to 72 hours postdose on C1D1","title":"t 1/2","type":"OTHER_PRE_SPECIFIED","unitOfMeasure":"hour"}